drugset / Trial / NCT04437888

Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty

NCT04437888

Phase 0 Completed 200 enrolled Dartmouth-Hitchcock Medical Center
RandomizedParallel-groupTriple-blindTreatment

Summary

Prospective randomized double blinded, placebo controlled study that will evaluate the effect of intra-operative ketamine administration on post-operative analgesic requirements and self-reported pain in patients undergoing total hip and total knee arthroplasty who demonstrate high levels of pain catastrophizing.

Timeline

Start
2020-09-14
Primary completion
2024-04-05
Completion
2024-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ketamine Small molecule 10 ug/kg